HIV-1 disease progression and AIDS-defining disorders in rural Uganda

Lancet

Volumn 350, Issue 9073, 1997, Pages 245-250

  Morgan, Dilys ^a   Maude, Gillian H ^b   Malamba, Samuel S ^a   Okongo, Martin J ^a   Wagner, Hans Ulrich ^a   Mulder, Daan W ^a   Whitworth, James A ^a  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RURAL POPULATION; SURVIVAL TIME; UGANDA;

EID: 0030759350     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)01474-8     Document Type: Article

References (38)

1. World Health Organisation. The HIV/AIDS pandemic: 1994 overview. Geneva: WHO; WHO/GPA/TCOSEP/94.4: 1994.
2. O'Farrell N, Lau R, Yoganathan K, Bradbeer CS, Griffin GE, Pozniak AL AIDS in Africans living in London. Genitourin Med. 71:1995;358-362.
3. Low N, Paine K, Clark R, Mahalingam M, Pozniak AL AIDS survival and progression in black Africans living in south London 1986-94. Genitourin Med. 72:1996;12-16.
4. Hu DJ, Fleming PL, Castro KGet al. How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions. J Acquir Immune Defic Syndr Hum Retrovirol. 10:1995;374-380.
5. Serwadda D, Sewankambo NK, Carswell JWet al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. ii:1985;849-852.
6. HIV/AIDS surveillance report. STD/AIDS Control Programme, Ministry of Health, Uganda. March 1996.
7. Provisional working estimates of adult HIV-1 prevalence at the end of 1994 by country, WHO Global AIDS Statistics. AIDS Care 1996; 8: 249-54.
8. Tembo G, Friesen H, Asiimwe-Okiror Get al. Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda. AIDS. 8:1994;1169-1171.
9. World Health Organisation. Acquired immune deficiency syndrome (AIDS): interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65: 221-28.
10. Morgan D, Malamba SS, Maude GHet al. An HIV-1 natural history cohort and survival times in rural Uganda. AIDS. 11:1997;633-640.
11. Mulder DW, Nunn AJ, Wagner U-H, Kamali A, Kengeya-Kayondo JF HIV-1 incidence and HIV-1-associated mortality in a rural Ugandan population cohort. AIDS. 8:1994;87-92.
12. Seeley JA, Wagner HU, Mulemwa J, Kengeya-Kayondo JF, Mulder DW The development of a community-based HIV/AIDS counselling service in a rural area in Uganda. AIDS Care. 3:1991;207-217.
13. Nunn AJ, Biryahwaho B, Downing RG, Van der Groen G, Ojwiya A, Mulder DW Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. AIDS. 7:1993;1057-1061.
14. Colebunders RL, Latif AS Natural history and clinical presentation of HIV-1 infection in adults. AIDS. 5(suppl 1):1991;S103-12.
15. Brettle RP, McNeil AJ, Gore SM, Bird AG, Leen CLS, Richardson A The Edinburgh City Hospital cohort: analysis of enrolment, progression and mortality by baseline covariates. QJM. 88:1995;479-491.
16. Kaplan JE, Spira TJ, Fishbein DF, Bozeman LH, Pinsky PF, Schonberger LB A six-year follow-up of HIV-infected homosexual men with lymphadenopathy. JAMA. 269:1988;2694-2697.
17. Leroy V, Msellati P, Lepage Pet al. Four years of natural history of HIV-1-infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-93. J Aquir Immune Defic Syndr Hum Retrovirol. 9:1995;415-421.
18. Veugelers PJ, Page KA, Tindall Bet al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconvertor Study. Am J Epidemiol. 140:1994;747-758.
19. Carré N, Deveau C, Belanger Fet al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS. 8:1994;797-802.
20. Hendriks JCM, Satten GA, Longini IMet al. Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men. AIDS. 10:1996;649-656.
21. Brettle RP, McNeil AJ, Burns Set al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS. 10:1996;419-430.
22. Flegg PJ The natural history of HIV infection: a study in Edinburgh drug users. J Infect. 29:1994;311-321.
23. Lepri AC, Pezzotti P, Dorrucci Met al. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. BMJ. 309:1994;1537-1542.
24. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR for the UK Haemophilia Centre Directors' Organisation. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996: 347: 1573-79.
25. Anzala OA, Nagelkerke NJD, Bwayo JJet al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis. 171:1995;686-689.
26. Aylward RB, Vlahow D, Muñoz A, Rapiti E Validation of the proposed World Health Organisation staging system for HIV disease and infection in a cohort of intravenous drug users. AIDS. 8:1994;1129-1133.
27. Lifson AR, Allen S, Wolf Wet al. Classification of HIV infection and disease in women from Rwanda: evaluation of the World Health Organisation HIV-1 staging system and recommended modifications. Ann Intern Med. 122:1995;262-270.
28. Del Amo J, Goh BT, Forster GE AIDS defining conditions in Africans resident in the United Kingdom. Int J STD AIDS. 7:1996;44-47.
29. Kumarasamy N, Soloman S, Jayaker Paul SA, Venilla R, Amalraj RE Spectrum of opportunistic infections among AIDS patients in Tamil Nadu. India. Int J STD AIDS. 6:1995;447-449.
30. Lucas S, Goodgame R, Kocjan G, Serwadda D Absence of pneumocystosis in Ugandan AIDS patients. AIDS. 3:1989;47-48.
31. Malin AS, Gwanzura LKZ, Klein S, Robertson VJ, Musvaire P, Mason PR Pneumocystis carinii pneumonia in Zimbabwe. Lancet. 346:1995;1258-1261.
32. Lange JMA HIV-1-related morbidity and mortality in sub-Saharan Africa: opportunities for prevention. AIDS. 7:1993;1675-1676.
33. De Cock KM, Soro B, Coulibaly IM, Lucas SB Tuberculosis and HIV-1 infection in Sub-Saharan Africa. JAMA. 268:1992;1581-1587.
34. Lucas SB, De Cock KM, Hounnou Aet al. Contributions of tuberculosis to slim disease in Africa. BMJ. 308:1994;1531-1534.
35. Montaner JSG, Le TN, Le N, Craib KJP, Schecter MT Application of the World Health Organisation system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS. 6:1992;719-727.
36. Chequer P, Hearst N, Hudes ESet al. Determinants of survival in adult Brazilian AIDS patients 1982-1989. AIDS. 6:1992;483-487.
37. Kitayaporn D, Tansuphaswadikul S, Lohsomboon Pet al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 11:1996;77-82.
38. Whitmore-Overton SE, Tillet HE, Evans BG, Allardice GM Improved survival from diagnosis of AIDS in adults cases in the United Kingdom and bias due to reporting delays. AIDS. 7:1993;415-420.